APA (7th ed.) Citation

Babalonis, S., Comer, S. D., Jones, J. D., Nuzzo, P., Lofwall, M. R., Manubay, J., . . . Walsh, S. L. (2021). Relative potency of intravenous oxymorphone compared to other µ opioid agonists in humans — pilot study outcomes. Psychopharmacology, 238(9), 2503. https://doi.org/10.1007/s00213-021-05872-1

Chicago Style (17th ed.) Citation

Babalonis, Shanna, Sandra D. Comer, Jermaine D. Jones, Paul Nuzzo, Michelle R. Lofwall, Jeanne Manubay, Kevin W. Hatton, Robert A. Whittington, and Sharon L. Walsh. "Relative Potency of Intravenous Oxymorphone Compared to Other µ Opioid Agonists in Humans — Pilot Study Outcomes." Psychopharmacology 238, no. 9 (2021): 2503. https://doi.org/10.1007/s00213-021-05872-1.

MLA (9th ed.) Citation

Babalonis, Shanna, et al. "Relative Potency of Intravenous Oxymorphone Compared to Other µ Opioid Agonists in Humans — Pilot Study Outcomes." Psychopharmacology, vol. 238, no. 9, 2021, p. 2503, https://doi.org/10.1007/s00213-021-05872-1.